DRUG · Unmapped registry intervention
Icotinib
Find medicine records ·
Find other trials using this name
Clinical trial
Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
NCT03754530
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
RADIATION · Unmapped registry intervention
WBRT or SRS
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedIcotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Brain Metastasesunresolved
Interventions
IcotinibDRUG
WBRT or SRSRADIATION
Sponsors & collaborators
Betta Pharmaceuticals Co., Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03754530 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.